1. Home
  2. LGND vs TNDM Comparison

LGND vs TNDM Comparison

Compare LGND & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • TNDM
  • Stock Information
  • Founded
  • LGND 1987
  • TNDM 2006
  • Country
  • LGND United States
  • TNDM United States
  • Employees
  • LGND N/A
  • TNDM N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • TNDM Medical/Dental Instruments
  • Sector
  • LGND Health Care
  • TNDM Health Care
  • Exchange
  • LGND Nasdaq
  • TNDM Nasdaq
  • Market Cap
  • LGND N/A
  • TNDM 1.9B
  • IPO Year
  • LGND 1992
  • TNDM 2013
  • Fundamental
  • Price
  • LGND $107.62
  • TNDM $19.28
  • Analyst Decision
  • LGND Strong Buy
  • TNDM Buy
  • Analyst Count
  • LGND 6
  • TNDM 15
  • Target Price
  • LGND $145.00
  • TNDM $46.07
  • AVG Volume (30 Days)
  • LGND 135.2K
  • TNDM 1.8M
  • Earning Date
  • LGND 05-06-2025
  • TNDM 05-01-2025
  • Dividend Yield
  • LGND N/A
  • TNDM N/A
  • EPS Growth
  • LGND N/A
  • TNDM N/A
  • EPS
  • LGND N/A
  • TNDM N/A
  • Revenue
  • LGND $167,133,000.00
  • TNDM $940,203,000.00
  • Revenue This Year
  • LGND $16.90
  • TNDM $8.70
  • Revenue Next Year
  • LGND $18.27
  • TNDM $11.06
  • P/E Ratio
  • LGND N/A
  • TNDM N/A
  • Revenue Growth
  • LGND 27.28
  • TNDM 25.74
  • 52 Week Low
  • LGND $67.72
  • TNDM $17.64
  • 52 Week High
  • LGND $129.90
  • TNDM $53.69
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.36
  • TNDM 32.06
  • Support Level
  • LGND $106.79
  • TNDM $19.12
  • Resistance Level
  • LGND $112.49
  • TNDM $21.15
  • Average True Range (ATR)
  • LGND 4.58
  • TNDM 0.94
  • MACD
  • LGND 0.12
  • TNDM 0.56
  • Stochastic Oscillator
  • LGND 43.87
  • TNDM 46.11

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Share on Social Networks: